Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials.

Int J Neuropsychopharmacol · 2021 · PMC8378078 · PMID 33890987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

2019 ) meta-analyses that reported the absence of efficacy of intranasal oxytocin on negative symptoms, our meta-analysis suggests a possible trend-level effect on negative symptoms of high-dose oxytocin, even after the exclusion of the Modabbernia study (2013).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.